Universe · entity

Palo Alto Investors LP

Institutional manager (13F) · CIK 1306923
13F holdings · as of 2026-03-31 · top 50 · reported portfolio $654M
#IssuerValueShares
1INSMED INC$68M415,269
2ACADIA PHARMACEUTICALS INC$64M2,872,695
3PTC THERAPEUTICS INC$63M921,607
4BIOMARIN PHARMACEUTICAL INC$39M685,182
5UNITED THERAPEUTICS CORP$37M62,809
6ANAPTYSBIO INC$35M638,161
7MIRUM PHARMACEUTICALS INC$30M325,175
8DYNE THERAPEUTICS INC$30M1,652,972
9BIOGEN INC$26M140,719
10DISC MEDICINE INC$26M401,719
11IOVANCE BIOTHERAPEUTICS INC$22M6,349,563
12SYNDAX PHARMACEUTICALS INC$20M864,986
13ANNEXON INC$16M2,948,090
14AMICUS THERAPEUTICS INC$16M1,113,045
15NOVOCURE LTD$14M1,280,439
16ULTRAGENYX PHARMACEUTICAL IN$12M596,495
17PROTHENA CORP PLC$12M1,208,568
18BICARA THERAPEUTICS INC$11M550,408
19CELLDEX THERAPEUTICS INC$9M296,408
20CAREDX INC$9M531,870
21ALKERMES PLC$9M242,560
22COMPASS THERAPEUTICS INC$8M1,514,504
23AGIOS PHARMACEUTICALS INC$7M213,601
24ALIGN TECHNOLOGY INC$7M41,520
25CAPRICOR THERAPEUTICS INC$7M229,763
26TRAVERE THERAPEUTICS INC$7M230,453
27TAYSHA GENE THERAPIES INC$6M1,391,382
28ACLARIS THERAPEUTICS INC$6M1,613,430
29DENALI THERAPEUTICS INC$5M234,582
30XENON PHARMACEUTICALS INC$3M51,345
31ORUKA THERAPEUTICS INC$3M59,985
32STOKE THERAPEUTICS INC$3M84,631
33EDWARDS LIFESCIENCES CORP$3M33,640
34NEUROCRINE BIOSCIENCES INC$2M18,117
35NUVATION BIO INC$2M508,846
36CYTOKINETICS INC$2M32,195
37EHEALTH INC$2M1,482,797
38CRISPR THERAPEUTICS AG$2M39,605
39BIONTECH SE-ADR$2M19,614
40PYXIS ONCOLOGY INC$1M1,010,510
41VERASTEM INC$1M246,093
42BICYCLE THERAPEUTICS PLC-ADR$937k201,890
43MADRIGAL PHARMACEUTICALS INC$935k1,787
44HUMANA INC$691k3,985
45COMPASS PATHWAYS PLC ADR$639k115,616
46XERIS BIOPHARMA HOLDINGS INC$606k104,410
47ABEONA THERAPEUTICS INC$488k108,865
48INSPIRE MEDICAL SYSTEMS INC$452k8,772
49UROGEN PHARMA LTD$441k24,500
50PROQR THERAPEUTICS NV$306k188,807
All filings on EDGAR ↗

Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.